Augmentin '125' and Adrenal neoplasm - a phase IV clinical study of FDA data

Summary:

Adrenal neoplasm is reported as a side effect among people who take Augmentin '125' (amoxicillin; clavulanate potassium), especially for people who are female, 50-59 old, also take Decadron, and have Light chain analysis increased.

The phase IV clinical study analyzes which people have Adrenal neoplasm when taking Augmentin '125'. It is created by eHealthMe based on reports of 10,373 people who have side effects when taking Augmentin '125' from the FDA, and is updated regularly.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

What is Adrenal neoplasm?

Adrenal neoplasm (abnormal growth of adrenal gland) is found to be associated with 208 drugs and 262 conditions by eHealthMe. Check the latest studies of Adrenal neoplasm.

On Jul, 04, 2026

10,373 people reported to have side effects when taking Augmentin '125'.
Among them, 15 people (0.14%) have Adrenal neoplasm.

Could Augmentin '125' cause Adrenal neoplasm?

Among these 15 people:

What is the gender of people who have Adrenal neoplasm when taking Augmentin '125'? *

female: 100 %
male: 0.0 %

What is the age of people who have Adrenal neoplasm when taking Augmentin '125'? *

What are other drugs people take besides Augmentin '125'? *

What are other side effects people have besides Adrenal neoplasm? *

Weight Decreased: 15 people, 100.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 100.00%
Neuropathy Peripheral (surface nerve damage): 15 people, 100.00%
Neck Pain: 15 people, 100.00%
Nausea (feeling of having an urge to vomit): 15 people, 100.00%
Multiple Myeloma (cancer of the plasma cells): 15 people, 100.00%
Mobility Decreased (ability to move is reduced): 15 people, 100.00%
Joint Pain: 15 people, 100.00%
Jaw Fracture: 15 people, 100.00%
Irritable Bowel Syndrome: 15 people, 100.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 12 people, 80.00%
Light Chain Analysis Increased: 12 people, 80.00%
Neoplasm Malignant (cancer tumour): 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '125' and have Adrenal neoplasm?

- Check whether Adrenal neoplasm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Augmentin '125':

Augmentin '125' (10,452 reports)

Adrenal neoplasm treatments and more:

Adrenal neoplasm (729 reports)

How severe was Adrenal neoplasm and when was it recovered:

Adrenal neoplasm in Augmentin '125'

Expand to all the drugs that have ingredients of amoxicillin; clavulanate potassium:

Adrenal neoplasm and drugs with ingredients of amoxicillin; clavulanate potassium

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Adrenal neoplasm:

Adrenal neoplasm (208 drugs)

Browse all the conditions that are associated with Adrenal neoplasm:

Adrenal neoplasm (262 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium (the active ingredients of Augmentin '125') and Augmentin '125' (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.